Free Trial

ZimVie (ZIMV) Competitors

ZimVie logo
$13.31 -0.01 (-0.08%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$13.30 -0.01 (-0.04%)
As of 02/21/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZIMV vs. CDRE, LQDA, INMD, PLSE, BLFS, AORT, MDXG, RXST, FNA, and BFLY

Should you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include Cadre (CDRE), Liquidia (LQDA), InMode (INMD), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Artivion (AORT), MiMedx Group (MDXG), RxSight (RXST), Paragon 28 (FNA), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.

ZimVie vs.

ZimVie (NASDAQ:ZIMV) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, community ranking, earnings and media sentiment.

Cadre has a net margin of 6.34% compared to ZimVie's net margin of -77.31%. Cadre's return on equity of 12.88% beat ZimVie's return on equity.

Company Net Margins Return on Equity Return on Assets
ZimVie-77.31% 2.90% 1.17%
Cadre 6.34%12.88%6.06%

ZimVie has a beta of 2.1, meaning that its stock price is 110% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500.

In the previous week, Cadre had 1 more articles in the media than ZimVie. MarketBeat recorded 2 mentions for Cadre and 1 mentions for ZimVie. Cadre's average media sentiment score of 0.70 beat ZimVie's score of 0.00 indicating that Cadre is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ZimVie
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cadre
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

95.6% of ZimVie shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 3.0% of ZimVie shares are owned by insiders. Comparatively, 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cadre received 13 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 55.17% of users gave Cadre an outperform vote while only 18.75% of users gave ZimVie an outperform vote.

CompanyUnderperformOutperform
ZimVieOutperform Votes
3
18.75%
Underperform Votes
13
81.25%
CadreOutperform Votes
16
55.17%
Underperform Votes
13
44.83%

Cadre has higher revenue and earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZimVie$457.43M0.80-$393.28M-$13.11-1.02
Cadre$482.53M2.83$38.64M$0.8340.58

ZimVie presently has a consensus price target of $19.50, indicating a potential upside of 46.51%. Cadre has a consensus price target of $39.67, indicating a potential upside of 17.76%. Given ZimVie's higher probable upside, analysts clearly believe ZimVie is more favorable than Cadre.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZimVie
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cadre
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Cadre beats ZimVie on 14 of the 17 factors compared between the two stocks.

Get ZimVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZIMV vs. The Competition

MetricZimVieDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$367.62M$3.90B$5.85B$9.15B
Dividend YieldN/A1.79%4.76%3.85%
P/E RatioN/A5.5116.5114.19
Price / Sales0.801.61450.0276.60
Price / Cash2.776.5738.0134.95
Price / Book0.860.837.644.63
Net Income-$393.28M-$146.24M$3.18B$245.69M
7 Day Performance1.29%1.54%-1.95%-2.68%
1 Month Performance-5.94%0.13%-0.23%-2.16%
1 Year Performance-31.04%217.04%16.69%12.90%

ZimVie Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZIMV
ZimVie
1.8623 of 5 stars
$13.31
-0.1%
$19.50
+46.5%
-29.8%$367.62M$457.43M0.002,600Upcoming Earnings
CDRE
Cadre
2.9308 of 5 stars
$35.14
-1.6%
$39.67
+12.9%
-5.2%$1.43B$482.53M42.342,435
LQDA
Liquidia
2.0541 of 5 stars
$16.20
+0.4%
$25.38
+56.6%
+13.0%$1.37B$17.49M-9.9450
INMD
InMode
1.9176 of 5 stars
$18.81
-1.3%
$22.25
+18.3%
-9.3%$1.31B$394.82M8.00480Positive News
PLSE
Pulse Biosciences
1.4628 of 5 stars
$20.99
-2.0%
N/A+108.2%$1.29B$700,000.000.00140News Coverage
Positive News
BLFS
BioLife Solutions
1.7187 of 5 stars
$27.77
+2.3%
$29.43
+6.0%
+52.4%$1.29B$143.27M-26.20440
AORT
Artivion
1.4458 of 5 stars
$30.08
-0.2%
$31.80
+5.7%
+44.6%$1.26B$354M-1,503.951,500
MDXG
MiMedx Group
3.0142 of 5 stars
$8.40
+1.4%
$12.00
+42.9%
-1.0%$1.23B$321.48M15.27870
RXST
RxSight
2.6433 of 5 stars
$29.81
-6.5%
$58.13
+95.0%
-46.2%$1.20B$128.29M-35.92220Upcoming Earnings
FNA
Paragon 28
2.0515 of 5 stars
$13.06
0.0%
$14.60
+11.8%
-4.2%$1.09B$216.39M-17.64343,000
BFLY
Butterfly Network
1.4135 of 5 stars
$4.77
+2.5%
$3.00
-37.0%
+323.3%$1.02B$65.90M-10.36460

Related Companies and Tools


This page (NASDAQ:ZIMV) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners